Your browser doesn't support javascript.
loading
Development of methylated cobalt-alkyne complexes with selective cytotoxicity against COX-positive cancer cell lines.
Baecker, Daniel; Sagasser, Jessica; Karaman, Serhat; Hörmann, Anton Amadeus; Gust, Ronald.
Afiliación
  • Baecker D; Department of Pharmaceutical Chemistry, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria.
  • Sagasser J; Department of Pharmaceutical Chemistry, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria.
  • Karaman S; Department of Pharmaceutical Chemistry, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria.
  • Hörmann AA; Department of Pharmaceutical Chemistry, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria.
  • Gust R; Department of Pharmaceutical Chemistry, CMBI-Center for Molecular Biosciences Innsbruck, CCB-Center for Chemistry and Biomedicine, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria.
Arch Pharm (Weinheim) ; 355(2): e2100408, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34893997
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Inhibidores de la Ciclooxigenasa 2 / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Arch Pharm (Weinheim) Año: 2022 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Inhibidores de la Ciclooxigenasa 2 / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Arch Pharm (Weinheim) Año: 2022 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Alemania